Related Experiment Video
Updated: Feb 7, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases
Dinara F Mesitskaya1, Abram L Syrkin1, Marina G Aksenova2
1Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Insights
Atherothrombosis causes significant global mortality. Targeting the thromboxane A2 pathway offers promising new therapeutic strategies for cardiovascular diseases.
Area of Science:
- Cardiovascular Medicine
- Pharmacogenomics
- Thrombosis Research
Background:
- Atherothrombosis is a leading cause of death worldwide.
- Novel therapeutic targets for cardiovascular diseases are urgently needed.
- Pharmacogenomics provides insights into disease mechanisms and treatment.
Purpose of the Study:
- To review current evidence on the thromboxane A2 pathway in cardiovascular diseases.
- To explore the potential of targeting the thromboxane A2 - thromboxane A synthase - thromboxane A2 receptor axis.
- To identify new therapeutic opportunities for atherothrombosis.
Main Methods:
- Literature review of recent studies.
- Analysis of pharmacogenomic data.
- Focus on the thromboxane A2 signaling pathway.
Main Results:
- The thromboxane A2 pathway is implicated in atherothrombosis pathogenesis.
- Pharmacogenomic insights highlight this axis as a potential therapeutic target.
- Systematic research in this area is advancing treatment options.
Conclusions:
- Targeting the thromboxane A2 axis presents a promising avenue for cardiovascular disease treatment.
- Further research into this pathway could lead to novel pharmacotherapies.
- This approach holds potential for managing patients with cardiovascular diseases.
Abstract:
Atherothrombosis-related diseases are one of the world's leading causes of mortality, and thus the search for new therapeutic approaches in this area remains a very urgent task. Modern pharmacogenomic technologies make it possible to obtain valuable data on disease pathogenesis and optimal therapeutic approaches. One promising research direction is the study of the thromboxane A2 - thromboxane A synthase - thromboxane A2 receptor axis. This review summarizes the recent evidence and suggests that systematic works in this area are creating new and promising opportunities in the treatment of patients with cardiovascular diseases.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
ATP Synthase: Structure
ATP Synthase: Mechanism
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

